ORIC — ORIC Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for ORIC Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	294	237	206	208	256
Prepaid Expenses
Total Current Assets	297	241	210	213	262
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.98	2.41	3.25	2.86	11.3
Long Term Investments
Other Long Term Assets
Total Assets	299	299	247	252	274
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9	15.2	15.4	20.5	24.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.22	25.7	24.8	27.9	31
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	290	273	222	224	243
Total Liabilities & Shareholders' Equity	299	299	247	252	274
Total Common Shares Outstanding